Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood First Edition Paper, prepublished online November 6, 2009; DOI 10.1182/blood-2009-04-215491.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Yu, J.
Right arrow Articles by Caligiuri, M. A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, J.
Right arrow Articles by Caligiuri, M. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted April 8, 2009; accepted October 9, 2009.

CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK cell subsets

Jianhua Yu1, Hsiaoyin Charlene Mao1, Min Wei1, Tiffany Hughes1, Jianying Zhang2, Il-kyoo Park1, Shujun Liu3, Susan McClory1, Guido Marcucci4, Rossana Trotta1 and Michael A. Caligiuri1,3

1 Department of Molecular Virology, Immunology, and Medical Genetics, The Ohio State University, Columbus, OH; 2 Center for Biostatistics, The Ohio State University, Columbus, OH; 3 Division of Hematology/Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH; 4 The Ohio State University Comprehensive Cancer Center, James Cancer Hospital and Solove Research Institute, Columbus, OH

* Corresponding author; email: michael.caligiuri{at}osumc.edu

Abstract

Human CD56bright natural killer (NK) cells possess little or no killer immunoglobulin-like receptors (KIR), high IFN-{gamma} production, but little cytotoxicity. CD56dim NK cells have high KIR expression, produce little IFN-{gamma}, yet display high cytotoxicity. We hypothesized that if human NK maturation progresses from a CD56bright to a CD56dim phenotype, an intermediary NK cell must exist which demonstrates more functional overlap than these two subsets, and we utilized CD94 expression to test our hypothesis. CD94highCD56dim NK cells express CD62L, CD2, and KIR at levels between CD56bright and CD94lowCD56dim NK cells. CD94highCD56dim NK cells produce less monokine-induced IFN-{gamma} than CD56bright NK cells but much more than CD94lowCD56dim NK cells due to differential IL-12-mediated STAT4 phosphorylation. CD94highCD56dim NK cells possess a higher level of granzyme B and perforin expression and CD94-mediated redirected killing than CD56bright NK cells but lower than CD94lowCD56dim NK cells. Collectively, our data suggest that density of CD94 surface expression on CD56dim NK cells identifies a functional and likely developmental intermediary between CD56bright and CD94lowCD56dim NK cells. This supports the notion that in vivo, human CD56bright NK cells progress through a continuum of differentiation that ends with a CD94lowCD56dim phenotype.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020